Dr. Heinz Redl recently joined the Editorial Board of Progress in Biomaterials. The multidisciplinary international scientific journal is publishing studies and reviews on the preparation of new and evaluation of existing biomaterials, their chemical, physical and biological properties and applications in the areas of tissue engineering, regenerative medicine and drug delivery.
Are you a medical professional working with traumatic injuries and feel like there are essential questions overlooked by science? Or are you a patient who feels like sharing first-hand experience? All of us have, in one way or another, experienced or witnessed injuries and subsequent treatment, but not many have ever had a chance to inform researchers about it. “Tell Us!” is looking for your input to improve research in the field of traumatology.
Trans4mMED - Transformative Patient Centred Personalised Medicine Initiative is a large-scale scientific and technological Future Emerging Technologies (FET) Flagship proposal that will address the grand challenge of developing regenerative, precision and personalised medicine to improve the quality of life of billions of patients worldwide.
At this year’s world congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) in Kyoto, Japan the LBI Trauma will be present as organizer of five symposia:
In course of the eighth business plan competition Best of Biotech the Ministry of Science, Research and Economy awarded the four best business plans in the field of life sciences. The award ceremony took place on November 22nd, 2017.
The Special Medtech award went to MorphoMed, a spin-off company of the LBI Trauma and associated member of the Austrian Cluster for Tissue Regeneration.
After 20 years as head of the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology Heinz Redl will hand over the lead in 2019. He will then continue to work at the LBI, providing his knowledge and expertise.
On the search for a successor the LBI Trauma wants to draw attention to the job advert. Applications are to be submitted via e-mail to Tanja Bielohaubek (email@example.com, LBG Career Center) until November 30th, 2017.
With LOIS – the Lab for Open Innovation in Science - the LBG offers a unique training program bringing together researchers from various disciplines and stages in their careers. The goal is to link and share knowledge from different fields with people inside and outside the scientific community for the benefit of research. The next LOIS will start in May 2018, application is still open until November 15th. For further information please visit: ois.lbg.ac.at
The research article on enhanced regeneration of critical-size long bone defects using hypertrophic chondrocyte grafts was published in Biomaterials (IF=8). Dr. Jon Bernhard, a Whitaker International Fellow to the LBI together with his colleagues showed the feasibility and promise of differentiated hypertrophic chondrocye grafts to regenerate critical-size femoral defects.
With support of AUVA and Lorenz-Böhler Hospital, the LBI has hosted the 9th Wiggers-Bernard Conference from May 3rd until 5th. The conference was entitled: “Pre-clinical Modeling in Sepsis: exchanging opinions and forming recommendations”. Over the period of three days, we had the privilege to host the crème de la crème of international experts (30 participants from 15 different countries) in clinical and pre-clinical sepsis.
The scientific advisory board chose Roland Kocijan’s contribution to be a highlight of OSTEOLOGIE 2017. "MicroRNAs are Correlated to Bone Microstructure and Histomorphometry in Patients with Idiopathic and Postmenopausal Osteoporosis" will be presented at the congress which will take place from March 23rd to 25th in Erlangen.